BRIEF published on 01/10/2025 at 13:05, 10 months 5 days ago Lumira Ventures Promotes Suman Rao to Principal Healthcare Innovation Venture Capital Lumira Ventures Suman Rao Principal Promotion
BRIEF published on 01/10/2025 at 13:05, 10 months 5 days ago Lumira Ventures promeut Suman Rao au poste de directeur Capital-risque Lumira Ventures Innovation Dans Le Domaine De La Santé Suman Rao Promotion Principale
PRESS RELEASE published on 01/10/2025 at 13:00, 10 months 5 days ago Lumira Ventures Announces Promotion of Suman Rao to Principal Lumira Ventures promotes Suman Rao, Ph.D., to Principal, recognizing her contributions to healthcare innovation. Read more about her journey and achievements Healthcare Innovation Venture Capital Lumira Ventures Biomedical Suman Rao
BRIEF published on 06/26/2024 at 13:05, 1 year 4 months ago Lumira Ventures Promotes Nikhil Thatte to Partner Promotion Life Sciences Lumira Ventures Healthcare Investment Nikhil Thatte
BRIEF published on 06/26/2024 at 13:05, 1 year 4 months ago Lumira Ventures promeut Nikhil Thatte comme partenaire Promotion Lumira Ventures Investissement Dans La Santé Sciences De La Vie Nikhil Thatte
PRESS RELEASE published on 06/26/2024 at 13:00, 1 year 4 months ago Lumira Ventures Announces Promotion of Nikhil Thatte to Partner Lumira Ventures promotes Nikhil Thatte to Partner in recognition of his exceptional contributions to healthcare innovation. Nikhil's strategic insights drive firm's success and partnerships Life Sciences Healthcare Innovation Lumira Ventures Investment Firm Nikhil Thatte
BRIEF published on 04/02/2024 at 13:05, 1 year 7 months ago Lumira Ventures Invests in Nocion Therapeutics to Advance Chronic Cough Treatment Lumira Ventures Nocion Therapeutics Chronic Cough Treatment Phase 2b Study Series B Financing
BRIEF published on 04/02/2024 at 13:05, 1 year 7 months ago Lumira Ventures investit dans Nocion Therapeutics pour faire progresser le traitement de la toux chronique Lumira Ventures Financement De Série B Nocion Thérapeutique Traitement De La Toux Chronique Étude De Phase 2b
PRESS RELEASE published on 04/02/2024 at 13:00, 1 year 7 months ago Lumira Ventures Announces Investment in Nocion Therapeutics to Revolutionize Chronic Cough Treatment Lumira Ventures invests in Nocion Therapeutics' Taplucanium for Chronic Cough treatment. Series B funding of $70M secured from leading investors Series B Funding Lumira Ventures Nocion Therapeutics Taplucanium Chronic Cough
BRIEF published on 03/07/2024 at 13:05, 1 year 8 months ago Lumira Ventures Celebrates Team Promotions Ahead of International Women's Day Healthcare Innovation Gender Equality International Women's Day Lumira Ventures Team Promotions
Published on 11/15/2025 at 18:10, 1 hour 32 minutes ago New to The Street Airs Landmark Show #700 Today at 6:30 PM ET on Bloomberg Television
Published on 11/15/2025 at 01:40, 18 hours 2 minutes ago Cyberlux Corporation Announces Operational Progress and Strategic Milestones in Q3 2025
Published on 11/14/2025 at 23:01, 20 hours 41 minutes ago 55 North Mining Receives Drill Permits for Last Hope Gold Project and Announces Grant of Stock Options
Published on 11/14/2025 at 23:00, 20 hours 42 minutes ago Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Published on 11/15/2025 at 16:15, 3 hours 26 minutes ago Luxshare Precision Achieves a Two-Notch Upgrade to MSCI ESG Rating A, Demonstrating Continuous Strength in Sustainable Development
Published on 11/14/2025 at 18:20, 1 day 1 hour ago Relief Therapeutics Shareholders Approve Business Combination with NeuroX
Published on 11/14/2025 at 16:58, 1 day 2 hours ago Résultats trimestriels au 30 septembre 2025 - ANR par action en hausse de +2,14 % depuis le 1er janvier 2025 - Fonds propres consolidés : 698 M€
Published on 11/13/2025 at 18:30, 2 days 1 hour ago RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 13 NOVEMBRE 2025
Published on 11/13/2025 at 18:30, 2 days 1 hour ago RESULTS OF THE COMBINED GENERAL MEETING ON NOVEMBER 13, 2025
Published on 11/13/2025 at 18:00, 2 days 1 hour ago Chiffre d’affaires du 1er semestre 2025/26 : 47,8 M€
